Lifecore Biomedical, Inc.
LFCR
$7.24
-$0.52-6.70%
NASDAQ
| 05/25/2025 | 02/23/2025 | 11/24/2024 | 08/25/2024 | 05/26/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.15M | -14.77M | -6.57M | -16.23M | -7.08M |
| Total Depreciation and Amortization | 1.91M | 2.08M | 2.04M | 1.99M | 2.01M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.61M | 16.33M | 7.11M | 6.13M | 9.34M |
| Change in Net Operating Assets | -1.03M | -2.44M | -8.70M | 7.47M | 4.44M |
| Cash from Operations | 5.35M | 1.20M | -6.11M | -643.00K | 8.72M |
| Capital Expenditure | -2.10M | -5.46M | -2.47M | -3.39M | -2.71M |
| Sale of Property, Plant, and Equipment | 0.00 | 7.00M | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.10M | 1.54M | -2.47M | -3.39M | -2.71M |
| Total Debt Issued | 128.57M | -- | -1.91M | 1.91M | 146.48M |
| Total Debt Repaid | -128.80M | -6.23M | -11.43M | -233.00K | -146.94M |
| Issuance of Common Stock | -- | 17.00K | 23.84M | 1.00K | 0.00 |
| Repurchase of Common Stock | -171.00K | -133.00K | -385.00K | -589.00K | -53.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -435.00K | 2.40M | -- | -107.00K |
| Cash from Financing | -402.00K | -6.78M | 12.52M | 1.09M | -614.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.85M | -4.04M | 3.94M | -2.94M | 5.39M |